MedPage Today on MSN
Moderate diet change tied to renal benefit in CKD
Findings suggest protein restriction doesn't have to be extreme ...
Surgical journey for participants (pts) in the MATTERHORN trial: A global, randomized, phase 3 study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results